Ledger.Open graph →
SEC Form D · filed November 7, 2023

Phylos Bioscience, Inc

Offering
—
Sold
$150K
Exemption
Rule 506(b)
Industry
Other
Location
PORTLAND, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

David A. Patterson · Portland, ORDirectorTimothy J. Gregory · Portland, ORDirectorNishan Karassik · PORTLAND, ORExec · DirectorMina J. Mishrikey · Portland, ORDirectorBarbara A. Peachey · Portland, ORExecRalph A. Risch · Portland, ORExec · DirectorRodney F. Emery · IRVINE, CADirectorRobert Thomas · Grand Cayman, Cayman IslandsDirectorMatthew Schaefer · Chicago, ILExec · DirectorMatthew A'Hearn · Chicago, ILExecHeather Paduck · Denver, COExec · DirectorTimothy Kuester · Denver, CODirectorJohn Scarborough · New York, NYExec · DirectorAdam Boehler · New York, NYDirectorWilliam Gorin · New York, NYDirectorCharles Fulford · New York, NYDirectorAndre Mack · New York, NYExecSean Josephs · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗